Personal and family.
Diagnoses, cardiovascular events in the family, treatments, habits and changes throughout life help to form the context.
CardioRisk: genetics and cardiovascular risk
CardioRisk brings together clinical, laboratory and genetic data to support a more individual preventive assessment and a more informed conversation about cardiovascular monitoring.
Family history, clinical measurements, habits and genetics form a single conversation.
Integrated assessment
History, tests and genetics analyzed together.
Pressure, cholesterol, glucose, age, history, habits and other conditions remain central. CardioRisk adds the genetic layer to this assessment.
Clinics and laboratories.
Data such as blood pressure and laboratory tests show the current state and can change with care, treatment and time.
Predispositions and scores.
Specific variants and the sum of many variants can add information, always within what the test analyzes and the limits of the method.
Two different questions
Estimating preventive risk is not investigating a hereditary heart disease.
The choice of test depends on the clinical question. One product does not automatically replace the other.
- 01
CardioRisk
Integrates genetics with clinical and laboratory factors to support risk estimation and preventive planning. The result needs to be interpreted in the context of the person.
- 02
Diagnostic investigation
When cardiomyopathy, arrhythmia, aortic disease, hereditary cholesterol or another specific condition is suspected, the team can recommend evaluation and testing aimed at this suspicion.
- 03
Professional assessment
History, physical examination, electrocardiogram, imaging, laboratory tests and clinical criteria help define which question needs to be answered.
How to interpret
An estimate is not a sentence.
Risk describes a possibility within a context and can be presented in different ways. Always ask what the number means to you.
- 01
Absolute and relative risk
They are different measurements. Ask the team to explain the period evaluated, the comparison used and the practical relevance of the difference.
- 02
Reference population
Genetic scores are constructed and validated in specific groups; accuracy may vary between populations.
- 03
Factors that change
Pressure, cholesterol, smoking, diabetes, physical activity and other elements continue to influence risk over time.
- 04
Proportional decision
A result can support conversation about follow-up, but should not alone lead to medication, procedure, or screening change.
To take to the consultation
Four questions make the result more useful.
The report gains meaning when the team explains the measures and relates them to your current care.
What risk is being estimated?
Confirm the event, period, comparison population and what information was included in the calculation.
What did genetics add?
Ask whether the result changed the assessment made with clinical and laboratory data and what the strength of the evidence is.
Is there a suspected diagnosis?
Understand whether any findings or history warrant specific investigation of a hereditary cardiovascular condition.
What remains the same?
Confirm appointments, tests, habits and treatments that remain indicated regardless of the genetic result.
Frequently asked questions
Questions about CardioRisk and monitoring.
Does CardioRisk diagnose heart disease?
No. It supports risk assessment by integrating different data. Diagnoses depend on history, clinical examination and investigations appropriate to the suspicion.
Does a high genetic risk mean I will have a cardiovascular event?
No. It's an estimate, not a certainty. Clinical, environmental and lifestyle factors also influence risk.
Does a low-risk result eliminate the need for follow-up?
No. Consultations, tests and preventive measures continue to be defined according to your health, age, history and clinical recommendations.
What if a hereditary heart disease is suspected?
The team can recommend specialized evaluation and a diagnostic test compatible with the suspicion. CardioRisk does not replace this investigation.
Does a VUS change my risk or treatment?
No. A variant of uncertain significance does not confirm diagnosis and should not guide treatment, surgery, surveillance, prognosis or predictive testing. In all NeoGenomica tests, the reported VUS are included in the Infinity VUS follow-up.
Stay informed
Know the test and prepare the context.
See what the test analyzes and take your history, medications and recent tests for a professional conversation.
Next step
Get to know CardioRisk and ask your questions before the test.
The team can explain access and what the test analyzes. The result is interpreted together with the history, clinical measurements and cardiovascular monitoring.
For patients and families
Information for each stage of the journey.
Start with the topic that comes closest to your question.
